CD33 and hepatocellular carcinoma: In human HCC, M-MDSCs are enriched in the fibrotic livers surrounding the tumor area, and the expression of M-MDSC marker CD33 is positively associated with tumor progression and negatively associated with the survival rate of HCC patients [68].